← Back to Clinical Trials
Recruiting NCT06262126

Virtual Reality for Non-cardiac Chest Pain

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Gastrointestinal Diseases
Sponsor Mayo Clinic
Study Type INTERVENTIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-02-14
Completion 2026-07-31
Interventions
Virtual Reality

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to determine if virtual reality (VR) will improve symptoms in non-cardiac chest pain (NCCP).

Eligibility Criteria

Inclusion Criteria: * Symptoms of non-cardiac chest pain (recurrent anginal-like or atypical chest pain) * Negative prior cardiac evaluation (at a minimum, including electrocardiogram) * Prior esophagogastroduodenoscopy and/or barium esophagram to rule out severe esophagitis, stricture, or motility abnormality Exclusion Criteria: * Initiation of a proton pump inhibitor (PPI) within 8 weeks * Major concomitant illness * Current drug or alcohol use that that would interfere with adherence to study requirements * Symptoms of vertigo or dizziness that would limit tolerability of the VR headset

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE GASTROINTESTINAL DISEASES TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}